Merck has won two CPhI Pharma Awards for innovative products for the pharmaceutical industry. The awards were announced at CPhI’s award gala in Madrid, Spain.
Darmstadt/Germany — CPhI (Convention on Pharmaceutical Ingredients) Pharma is a global organization that connects people within the pharmaceutical industry and celebrates thinkers, creators and companies.
Parteck MXP Excipient won for “Excellence in Excipients”. The product is a new polyvinyl alcohol excipient for the formulation of stable amorphous solid dispersions by hot melt extrusion, providing enhanced solubility of active pharmaceutical ingredients (APIs) and stable, high drug loads. The new excipient is applicable for a variety of final formulations with different release kinetics and offers the formulator flexibility in designing a drug product that fits the respective API and desired therapeutic effect.
Merck’s modified amino acids won for “Excellence in Bioprocessing and Manufacturing”. The modified amino acids Phospho-Tyrosine disodium salt and Sulfo-Cysteine sodium salt are components for biomanufacturing and mAb processes, designed to simplify fed batch processes in applying a single-feed strategy.